AU2014201494B2 - Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels - Google Patents

Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels Download PDF

Info

Publication number
AU2014201494B2
AU2014201494B2 AU2014201494A AU2014201494A AU2014201494B2 AU 2014201494 B2 AU2014201494 B2 AU 2014201494B2 AU 2014201494 A AU2014201494 A AU 2014201494A AU 2014201494 A AU2014201494 A AU 2014201494A AU 2014201494 B2 AU2014201494 B2 AU 2014201494B2
Authority
AU
Australia
Prior art keywords
opening
spinal
nerve tissue
spinal level
element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014201494A
Other versions
AU2014201494A1 (en
Inventor
Mir A. Imran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spinal Modulation LLC
Original Assignee
Spinal Modulation LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/873,535 priority Critical
Priority to US60/873,464 priority
Priority to AU2007329253A priority patent/AU2007329253B2/en
Application filed by Spinal Modulation LLC filed Critical Spinal Modulation LLC
Priority to AU2014201494A priority patent/AU2014201494B2/en
Publication of AU2014201494A1 publication Critical patent/AU2014201494A1/en
Application granted granted Critical
Publication of AU2014201494B2 publication Critical patent/AU2014201494B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Abstract

Abstract Simultaneous stimulation of spinal anatomy at various locations. Allows targeted stimulation of particular spinal levels and specific tissue like ganglion cells, rather than blanket stimulation. Device consists of elongate structure positioned within an epidural space, with openings aligned with spinal levels. Device has one lumen to allow passage of multiple elements like electrodes for stimulation. Distance between openings can be adjusted. Elements can be advanced, torqued, or steered.

Description

WO 2008/070807 PCT/US2007/086696 DELIVERY DEVICES, SYSTEMS AND METHODS FOR STIMULATING NERVE TISSUE ON MULTIPLE SPINAL LEVELS CROSS-REFERENCES TO RELATED APPLICATIONS 5 [0001] This application claims priority of provisional patent application no. 60/873,535 (Attorney Docket No. 10088-707.101), filed on December 6, 2006, and provisional patent application no. 60/873,464 (Attorney Docket No. 10088-706.101), filed on December 6, 2006, both of which are incorporated herein by reference for all purposes. 10 STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT [0002] NOT APPLICABLE REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER 15 PROGRAM LISTING APPENDIX SUBMITTED ON A COMPACT DISK. [00031 NOT APPLICABLE BACKGROUND OF THE INVENTION [0004] The application of specific electrical energy to the spinal cord for the purpose of 20 managing pain has been actively practiced since the 1960s. It is known that application of an electrical field to spinal nervous tissue can effectively mask certain types of pain transmitted from regions of the body associated with the stimulated nervous tissue. Such masking is known as paresthesia, a subjective sensation of numbness or tingling in the afflicted bodily regions. Application of electrical energy has been based on the gate control theory of pain. 25 Published in 1965 by Melzack and Wall, this theory states that reception of large nerve fiber information, such as touch, sense of cold, or vibration, would turn off or close the gate to reception of painful small nerve fiber information. The expected end result would, therefore, be pain relief. Based on the gate control theory, electrical stimulation of large fibers of the spinal cord cause small fiber information to be reduced or eliminated at that spinal segment 30 and all other information downstream from that segment would be reduced or eliminated as 1 WO 2008/070807 PCT/US2007/086696 well. Such electrical stimulation of the spinal cord, once known as dorsal column stimulation, is now referred to as spinal cord stimulation or SCS. [00051 Figs. lA-1B illustrate conventional placement of an SCS system 10. Conventional SCS systems include an implantable power source or implantable pulse generator (IPG) 12 5 and an implantable lead 14. Such IPGs 12 are similar in size and weight to pacemakers and are typically implanted in the buttocks of a patient P. Using fluoroscopy, the lead 14 is implanted into the epidural space E of the spinal column and positioned against the dura layer D of the spinal cord S, as illustrated in Fig. 1B. The lead 14 is implanted either through the skin via an epidural needle (for percutaneous leads) or directly and surgically through a mini 10 laminotomy operation (for paddle leads). [0006] Fig. 2 illustrates example conventional paddle leads 16 and percutaneous leads 18. Paddle leads 16 typically have the form of a slab of silicon rubber having one or more electrodes 20 on its surface. Example dimensions of a paddle lead 16 is illustrated in Fig. 3. Percutaneous leads 18 typically have the form of a tube or rod having one or more electrodes 15 20 extending therearound. Example dimensions of a percutaneous lead 18 is illustrated in Fig. 4. [00071 Implantation of a percutaneous lead 18 typically involves an incision over the low back area (for control of back and leg pain) or over the upper back and neck area (for pain in the arms). An epidural needle is placed through the incision into the epidural space and the 20 lead is advanced and steered over the spinal cord until it reaches the area of the spinal cord that, when electrically stimulated, produces a comfortable tingling sensation (paresthesia) that covers the patient's painful area. To locate this area, the lead is moved and turned on and off while the patient provides feedback about stimulation coverage. Because the patient participates in this operation and directs the operator to the correct area of the spinal cord, the 25 procedure is performed with local anesthesia. [00081 Implantation of paddle leads 16 typically involves performing a mini laminotomy to implant the lead. An incision is made either slightly below or above the spinal cord segment to be stimulated. The epidural space is entered directly through the hole in the bone and a paddle lead 16 is placed over the area to stimulate the spinal cord. The target area for 30 stimulation usually has been located before this procedure during a spinal cord stimulation trial with percutaneous leads 18. 2 WO 2008/070807 PCT/US2007/086696 [0009] Although such SCS systems have effectively relieved pain in some patients, these systems have a number of drawbacks. To begin, as illustrated in Fig. 5, the lead 14 is positioned upon the spinal cord dura layer D so that the electrodes 20 stimulate a wide portion of the spinal cord and associated spinal nervous tissue. The spinal cord is a 5 continuous body and three spinal levels of the spinal cord are illustrated. For purposes of illustration, spinal levels are sub-sections of the spinal cord S depicting that portion where the dorsal root DR and ventral root VR join the spinal cord S. The peripheral nerve N divides into the dorsal root DR and the dorsal root ganglion DRG and the ventral nerve root VR each of which feed into the spinal cord S. An ascending pathway 17 is illustrated between level 2 10 and level 1 and a descending pathway 19 is illustrated from level 2 to level 3. Spinal levels can correspond to the veterbral levels of the spine commonly used to describe the vertebral bodies of the spine. For simplicity, each level illustrates the nerves of only one side and a normal anatomical configuration would have similar nerves illustrated in the side of the spinal cord directly adjacent the lead. 15 [0010] Motor spinal nervous tissue, or nervous tissue from ventral nerve roots, transmits muscle/motor control signals. Sensory spinal nervous tissue, or nervous tissue from dorsal nerve roots, transmit pain signals. Corresponding dorsal and ventral nerve roots depart the spinal cord "separately"; however, immediately thereafter, the nervous tissue of the dorsal and ventral nerve roots are mixed, or intertwined. Accordingly, electrical stimulation by the 20 lead 14 often causes undesirable stimulation of the motor nerves in addition to the sensory spinal nervous tissue. [00111 Because the electrodes span several levels the generated stimulation energy 15 stimulates or is applied to more than one type of nerve tissue on more than one level. Moreover, these and other conventional, non-specific stimulation systems also apply 25 stimulation energy to the spinal cord and to other neural tissue beyond the intended stimulation targets. As used herein, non-specific stimulation refers to the fact that the stimulation energy is provided to all spinal levels including the nerves and the spinal cord generally and indiscriminately. Even if the epidural electrode is reduced in size to simply stimulate only one level, that electrode will apply stimulation energy indiscriminately to 30 everything (i.e. all nerve fibers and other tissues) within the range of the applied energy. Moreover, larger epidural electrode arrays may alter cerebral spinal fluid flow thus further altering local neural excitability states. 3 WO 2008/070807 PCT/US2007/086696 [0012] Another challenge confronting conventional neurostimulation systems is that since epidural electrodes must apply energy across a wide variety of tissues and fluids (i.e. CSF fluid amount varies along the spine as does pia mater thickness) the amount of stimulation energy needed to provide the desired amount of neurostimulation is difficult to precisely 5 control. As such, increasing amounts of energy may be required to ensure sufficient stimulation energy reaches the desired stimulation area. However, as applied stimulation energy increases so too increases the likelihood of deleterious damage or stimulation of surrounding tissue, structures or neural pathways. [00131 Improved stimulation systems and methods are desired that enable more precise and 10 effective delivery of stimulation energy. At least some of these objectives will be met by the present invention. BRIEF SUMMARY OF THE INVENTION [0014] The present invention provides devices, systems and methods for simultaneously stimulating the spinal anatomy at various locations, such as spinal levels, along the spinal 15 cord. The spinal cord is a continuous body and may be considered to include various spinal levels. For example, a spinal level may be considered a sub-section of the spinal cord wherein a dorsal root and ventral root join the spinal cord. Spinal levels may also correspond to the vertebral levels of the spine commonly used to describe the vertebral bodies of the spine. It may be desired to stimulate particular spinal levels, rather than blanketly stimulating 20 a wide area, so as to more effectively treat pain symptoms and reduce deleterious side effects. The present invention provides devices, systems and methods for such targeted stimulation at various spinal levels. In addition, some embodiments provide additional specificity within each targeted level, such as selective stimulation of specific tissue, such as the dorsal root ganglion. 25 [00151 By stimulating multiple levels of the spinal column with the use of a single device, a single access path is created to an implantable pulse generator (IPG) rather than individual access paths for each lead at each spinal level to an IPG. By reducing the number of pathways, the procedure complexity, time and recovery are reduced. It may be appreciated that the devices, systems and methods of the present invention may also be used to stimulate 30 other portions of the spinal anatomy or other anatomies. [0016] In a first aspect of the present invention, a delivery device is provided for delivering elements to nerve tissue on different spinal levels. In one embodiment, the device comprises 4 WO 2008/070807 PCT/US2007/086696 an elongate structure shaped for positioning within an epidural space, wherein the elongate structure has a first opening alignable with a first spinal level and a second opening concurrently alignable with a second spinal level. The elongate structure includes at least one lumen configured to allow passage of at least one element through the first opening toward 5 nerve tissue on the first spinal level and passage of at least one element through the second opening toward nerve tissue on the second spinal level. [0017] Optionally, the elongate structure may comprise a first portion having the first opening and a second portion having the second opening, wherein the first and second portions move relative to each other so as to adjust a distance between the openings. When 10 the first and second spinal levels are not adjacent to each other, the first and second portions may be moved to provide appropriate alignment of the openings. [00181 In some embodiments, the openings face lateral to a midline of the epidural space. In other embodiments, the openings face longitudinal to a midline of the epidural space. Optionally, the first opening faces a direction on the first spinal level and another opening 15 faces in a substantially opposite direction on the first spinal level. In some embodiments, the distance between the openings is fixed. [0019] Typically, the at least one lumen comprises an individual lumen extending to the first opening and an individual lumen extending to the second opening. However, the elements may extend through one or more common lumens. In some embodiments, the 20 delivery device further comprises a mechanism to fix the at least one element in relation to the elongate structure. [0020] The openings may have any suitable shape. In some embodiments, the first opening is shaped to allow longitudinal translation of the at least one element within the first opening. In such instances, the first opening may have an oblong shape. 25 [00211 In another aspect of the present invention, a system is provided for treating nerve tissue on different spinal levels. In some embodiments, the system comprises an elongate structure shaped for positioning within an epidural space, wherein the elongate structure has a first opening alignable with a first spinal level and a second opening concurrently alignable with a second spinal level. A first element is extendable through the first opening and 30 positionable so as to treat nerve tissue on the first spinal level, and a second element is extendable through the second opening and positionable so as to treat nerve tissue on the second spinal level. 5 WO 2008/070807 PCT/US2007/086696 [0022] Typically, the first element comprises a lead having at least one electrode. In such embodiments, the first element may be positionable so as to selectively stimulate a dorsal root ganglion on the first spinal level. Alternatively, the first element may comprise an agent delivery device. In such embodiments, the first element may be positionable to deliver the 5 agent to a dorsal root ganglion or other tissue on the first spinal level. [00231 In some embodiments, at least a portion of the first element is steerable. Alternatively or additionally, the first element may extend through a lumen in the elongate structure and be rotatable within the lumen. Likewise, the first element may be longitudinally translatable within the first opening. 10 [0024] In some embodiments, the elongate structure comprises a first portion having the first opening and a second portion having the second opening, wherein the first and second portions move relative to each other so as to adjust a distance between the openings. This may be useful when the first and second spinal levels are not adjacent to each other. [0025] In some embodiments, the elongate structure includes a third opening concurrently 15 alignable with the first spinal level and a third element extendable through the third opening and positionable so as to treat nerve tissue on the first spinal level. In such instances, the first element and third element may comprise leads each having at least one electrode and wherein the first element is positionable so as to selectively stimulate dorsal root ganglion on the first spinal level and the third element is positionable so as to selectively stimulate a different 20 dorsal root ganglion on the first spinal level. [00261 In another aspect of the present invention, a method is provided for delivering elements to nerve tissue on different spinal levels. In some embodiments, the method comprises advancing an elongate structure into an epidural space, wherein the elongate structure has a first opening and a second opening, and positioning the elongate structure so 25 that the first opening substantially aligns with a first spinal level the second opening substantially aligns with a second spinal level. [0027] In some embodiments, the method further comprises extending a first element through the first opening toward a nerve tissue on the first spinal level. When the first element comprises a lead having at least one electrode, the method may further comprise 30 stimulating the nerve tissue on the first spinal level. In some instances, the nerve tissue comprises a dorsal root ganglion. 6 WO 2008/070807 PCT/US2007/086696 [0028] In some embodiments, the method further comprises manipulating the first element to direct the distal end toward the nerve tissue on the first spinal level. In some instances, manipulating comprises advancing, retracting, torqueing, curving or steering the first element. 5 [00291 It may be appreciated that when the first element comprises an agent delivery device, the method further comprises delivering an agent to the nerve tissue on the first spinal level. [0030] In some embodiments, the method further comprises extending a second element through the second opening toward a nerve tissue on the second spinal level. 10 [00311 In some instances, the elongate structure comprises a first portion having the first opening and a second portion having the second opening. In such instances, positioning may comprise moving at least one of the portions in relation to the other. Alternatively or additionally, positioning may comprise moving the openings in relation to each other. The first and second spinal levels may or may not be adjacent to each other. 15 [0032] Optionally, the elongate structure may have a third opening. In such instances, positioning may comprise aligning the third opening with the first spinal level. In such instances, the method may further comprise extending a first element through the first opening toward a nerve tissue on the first spinal level and extending a third element through the third opening toward a different nerve tissue on the first spinal level. In some 20 embodiments, the nerve tissue on the first spinal level comprises a dorsal root ganglion and the different nerve tissue on the first spinal level comprises a different dorsal root ganglion. [00331 In yet another aspect of the present invention, a system is provided for treating nerve tissue on different spinal levels. In some embodiments, the system comprises an elongate member shaped for positioning within an epidural space, and a first lead having a 25 lumen and at least one electrode, wherein the first lead is configured to track over the elongate member by passing the elongate member through the lumen so that the at least one electrode is positioned near a nerve tissue on a first spinal level. The elongate member may comprise a rail, rod or guidewire. In some embodiments, the system further comprises a second lead having a lumen and at least one electrode, wherein the second lead is configured 30 to track over the elongate member by passing the elongate member through its lumen so that its at least one electrode is positioned near a nerve tissue on a second spinal level. In such instances, the first and second spinal levels may not be adjacent to each other. In some 7 WO 2008/070807 PCT/US2007/086696 embodiments, the nerve tissue comprises a dorsal root ganglion. And, in some embodiments, the system further comprises an anchoring device configured to anchor the elongate member to a vertebrae. [00341 In still another aspect of the present invention, a method is provided for treating 5 nerve tissue on different spinal levels. In some embodiments, the method comprises advancing an elongate member into an epidural space, tracking a first lead having at least one electrode over the elongate member, and positioning the at least one electrode near a nerve tissue on a first spinal level. In some embodiments, the method further comprises implanting the elongate member in the epidural space. Implanting may comprise anchoring the elongate 10 member to a vertebrae. The method may further comprise tracking a second lead having at least one electrode over the elongate member. Optionally, the method may comprise positioning the at least one electrode of the second lead near a nerve tissue on a second spinal level. [00351 Other objects and advantages of the present invention will become apparent from 15 the detailed description to follow, together with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS [0036] Fig. 1A-1B, 2, 3, 4, 5 illustrate prior art. [0037] Fig.6 illustrates positioning of a telescoping device of the present invention so as to optionally simultaneously stimulate nerve tissue on various spinal levels. 20 [0038] Fig. 7 illustrates a non- telescoping device of the present invention used to optionally simultaneously stimulate nerve tissue on various spinal levels. [0039] Figs. 8A, 8B, 8C illustrate an embodiment of a grouped lead device having an elongate structure which allows advancement of leads through slots or ports. [0040] Figs. 9A, 9B, 9C illustrate optional adjustments of the leads within the ports. 25 [0041] Fig. 10 illustrates an electrode shaped to increase contact area or wrap around a nerve tissue. [0042] Fig. 11 illustrates an electrode having a coil shape. [0043] Fig. 12 illustrates a cross-sectional view of an elongate structure of the present invention positioned near a DRG on a single spinal level. 8 WO 2008/070807 PCT/US2007/086696 [0044] Fig. 13 illustrates a side view of the device of Fig. 12 shown extending between multiple spinal levels. [0045] Figs. 14A-14B provide a more detailed view of the device of Fig. 13. [0046] Fig. 15 illustrates the placement of a rail, rod, guidewire or other elongate member 5 or structure in an epidural space, particularly longitudinally through the foramens of each vertebrae. [0047] Fig. 16 illustrates individual leads, each including a lumen extending through at least a portion of the lead that is used for tracking over a structure. [0048] Fig. 17 illustrates a plurality of leads tracked over a structure, each lead positioned 10 in a target location near a DRG. DETAILED DESCRIPTION OF THE INVENTION [0049] In preferred embodiments, the devices, systems and methods stimulate the various spinal levels at specific nerve anatomies, such as the dorsal root DR or more specifically the 15 dorsal root ganglion DRG. The following examples vill illustrate specific stimulation of the dorsal root ganglia of various levels, however the embodiments are not so limited. Also, the following examples utilize various types of leads to provide stimulation. It may be appreciated that other elements, such as agent delivery devices, may be used alternatively or in addition to the leads for delivery of an agent to a specific nerve anatomy. 20 [0050] Fig. 6 illustrates positioning of a device 400 of the present invention so as to optionally simultaneously stimulate various levels (levels 1, 2, 3 in this example) of the spinal cord S. The device 400 is shown positioned within an epidural space of the spinal column, residing against the dura layer of the spinal cord. This is achieved by inserting the device through the skin via an epidural needle. Fig. 6 illustrates the device 400 positioned via an 25 antegrade approach, however it may be appreciated that a retrograde approach may also be used. [0051] In this embodiment, the device 400 comprises an elongate structure or shaft 404 wherein the shaft 404 has a first opening or port 406 which is alignable with a first spinal level and a second opening or port 406 which is concurrently alignable with a second spinal 30 level. More particularly, in this embodiment the shaft 404 is telescoping (for example, three telescoping portions 404a, 404b, 404c are shown). Each telescoping portion includes at least 9 WO 2008/070807 PCT/US2007/086696 one opening or port 406 and at least one lumen configured to allow passage of at least one element, such as a lead 410, through the opening or port 406. The ports 406 face lateral to a midline of the epidural space so that the lead 410 may be advanced away from the midline in a lateral direction, such as toward a DRG. In some er-bodiments, each telescoping portion 5 includes two ports, one on each side, so that each faces an opposite direction on the same spinal level. This provides simultaneous access to DRGs on the same spinal level on both sides of the spinal cord. Typically, ports 406 are located on various telescoping portions so that the distance between the ports 406 may be adjusted by moving the telescoping portions relative to each other (e.g. retracting or advancing). Thus, the ports 406 are alignable with 10 various spinal levels so that nerve tissue can be simultaneously accessed on multiple spinal levels. [0052] The telescoping portions 404a, 404b, 404c may be comprised of various materials, preferably a flexible polymer. The portions 404a, 404b, 404c may be supported by a stylet during placement. The telescoping portions 404a, 404b, 404c may have various cross 15 sectional shapes, including flat (which may be oval, rectangular, etc) and thick (which may be circular, square, etc). [0053] As mentioned, one or more elements, such a: leads 410, are advanceable through the shaft 404 so that each lead 410 exits a port 406 and is advanceable toward a target tissue, such as a DRG. Each lead 410 includes one or more electrodes 412, and the lead 410 is 20 positionable so that the one or more electrodes 412 are desirably positioned in, on, or about the DRG. Such positioning may include manipulation such as advancing, retracting, torqueing, curving or steering the lead 410. Some examples of such manipulations will be described later in relation to Figs. 9A-9C and are applicable to this embodiment as well. This may be repeated for positioning of additional leads 410 at the same level or other levels. 25 [0054] The device 400 is electrically connected to a power source or implantable pulse generator (IPG) 402, as shown, which is implanted in the body of the patient. The IPG 402 provides stimulation energy to the electrodes 412. Thus, in Fig. 6, the device 400 is shown extending longitudinally along the spinal column and leads 410 are shown extending to a DRG at level 1 (DRG1), a DRG at level 2 (DRG2) and a DRG at level 3 (DRG3). Thus, the 30 device 400 extends across multiple levels in the form of a grouped lead providing a single extension to the IPG 402. DRG1, DRG2, DRG3 can be stimulated simultaneously or in any pattern which provides the most desirable therapeutic result, such as pain management. 10 WO 2008/070807 PCT/US2007/086696 [0055] Fig. 7 illustrates another embodiment of a device 400 of the present invention for delivering leads 410 so as to optionally simultaneously stimulate various levels (levels 1, 2, 3 in this example) of the spinal cord S. Again, the device 400 comprises an elongate structure or shaft 420 shaped for positioning within an epidural space. The shaft 420 has a first 5 opening or port 422 alignable with a first spinal level and a second opening or port 422 alignable with a second spinal level. In this embodiment, the shaft 420 is non-telescoping so the distance between the ports 422 is fixed. Typically, the ports 422 are spaced so as to align with spinal levels of the average population. However, it may be appreciated that a variety of shafts 420 may be provided with different port 422 spacing to allow the practitioner the 10 option of choosing the most appropriate spacing for the individual patient. In this embodiment, the ports 422 face longitudinal to a midline of the epidural space. However, it may be appreciated that the ports 422 may alternatively face lateral to the midline of the epidural space. [0056] The elongate structure or shaft 420 includes at least one lumen 411 configured to 15 allow passage of at least one element, such as a lead 410, through a port 422 toward nerve tissue on a desired spinal level. To position an individual lead 410 having at least one electrode 412 thereon near a target DRG, the shaft 420 is positioned so that a port 422 is desirably aligned with the target DRG. The lead 410 is then advanced through the shaft 420 so that the lead 410 exits the aligned port 422 and advances toward the target DRG. The lead 20 410 is then positioned so that the one or more electrodes 412 are desirably positioned in, on, or about the DRG. Such positioning may include manipulation such as advancing, retracting, torqueing, curving or steering the lead 410. Some examples of such manipulations will be described later in relation to Figs. 9A-9C and are applicable to this embodiment as well. Such manipulation may also compensate for any differences in anatomical spacing of the 25 levels of the spinal cord S. This may be repeated for positioning of additional leads 410 at the same level or other levels. Optionally, this embodiment of the device 400 may be adapted to be telescoping. [0057] Figs. 8A-8C illustrate another embodiment of a grouped lead device 400. In this embodiment, the device 400 comprises an elongate structure or shaft 430 shaped for 30 positioning within an epidural space. The shaft 430 includes at least one lumen 433 configured to allow passage of at least one element, such as a lead 410, and at least one opening, slot or port 434 which allows advancement of leads 410 through the slots or ports 434. Individual leads 410 may be advanced through lumens 433 in the structure 430 and exit 11 WO 2008/070807 PCT/US2007/086696 through ports 434 disposed near its distal end 436. In this embodiment, the leads 410 each include at least one electrode 412 for stimulating the anatomy, particularly the DRG. In this embodiment, the structure 430 has a flat cross-section (Fig. 8B) wherein the lumens 433 extend in parallel within the structure 430 and the ports 434 are aligned along the side of the 5 structure (Fig. 8C). It may be appreciated that the ports 434 may be aligned along one or both sides of the structure to allow access to DRGs on either side of the spinal cord S. Again, axial distances between the ports 434 are designed to generally direct the leads 410 toward the target DRGs. Adjustment of the actual distances between the leads 410 can be made by movement of the leads 410 within the lumens 433 (advancement, retraction, torquing, etc.). 10 [0058] Figs. 9A-9C illustrate optional adjustments of the leads 410 within the ports 434. Typically the leads 410 will be pre-shaped so as to extend through the ports 434 at an angle. Various angles may be achieved by using leads 410 having different pre-set curvatures. In some embodiments, angular adjustment of the distal end of the lead 410 (Fig. 9A) can be made with the use of a pullwire. Axial movement (Fig. 9B) can be achieved by advancing 15 and retracting the leads 410 within the lumens 433. Radial movement (Fig. 9C) can be achieved by rotating or torquing the leads 410 within the lumens 433. [00591 The leads 410 described herein may include one or more electrodes 412 of various designs. Typically, the electrodes 412 are illustrated as cuff or band electrodes extending around the lead 410. It may be appreciated that the electrodes 412 may have a variety of 20 shapes and sizes including a pointed tip which is used to contact or pierce a tissue, an array along a flat portion of a lead, an array at least partially extending around the circumference of a lead, etc. Figs. 10-11 illustrate some alternative embodiments of electrodes 412 that may be used with the present invention. The distal end of the lead 410 or the electrode 412 may be shaped so as to increase contact area or wrap around the DRG (Fig. 10). Or, the electrode 25 412 may have other shapes, such as a coil (Fig. 11). These designs may also improve anchoring of the lead 410 to the target tissue. [0060] Referring back to Fig. 8A, once the lead 410 positions have been desirably adjusted, the leads 410 are fixed in place with the use of a fixing mechanism 440. In some embodiments, the mechanism 440 clamps the slotted structure 430 so as to hold the leads 410 30 in place by frictional forces. Other fixation mechanisms may alternatively be used. The leads 410 are connected with an IPG 402 which is implanted in the body of the patient. The IPG 402 provides stimulation energy to the electrodes 412. Typically, the slotted structure or 12 WO 2008/070807 PCT/US2007/086696 shaft 430 is anchored to tissue near the IPG or along the shaft 430 outside of the spinal column. This assists in reducing any possible migration or movement. Thus, in some embodiments, the shaft 430 includes a tissue anchor 445 which may be used to anchor the shaft 430 to the surrounding tissue. In this example, the tissue anchor 445 includes at least 5 one suture hole 447 through which suture may be passed to suture the anchor 445 to the tissue. [0061] The previously described embodiments of devices 400 of the present invention are described and illustrated to be positionable within an epidural space, such as along the midline of the spinal column or at any distance from the midline along the spinal column. 10 Optionally, these and other embodiments of the devices 400 may be positioned within the epidural space at a distance from the midline which aligns the elongate structure with the dorsal root ganglions. Such placement is illustrated in Fig. 12, wherein a cross-section of the elongate structure 200 is shown positioned near a DRG on a single spinal level. [0062] Fig. 13 illustrates an embodiment of a device 400 of the present invention 15 positioned as illustrated in Fig. 12. As shown, the device 400 comprises an elongate structure 200 extending longitudinally through the foramens of each vertebrae V. It may be appreciated that the elongate structure 200 may be positioned at a variety of locations adjacent or near the DRG while maintaining the longitudinal orientation. As shown, the structure 200 allows advancement of multiple leads 232 therethrough so that each lead 232 is 20 able to stimulate a DRG on an individual level. Thus, DRGs on multiple spinal levels may be simultaneously stimulated or stimulated in any pattern which provides the most desirable therapeutic result. The structure 200 also provides a single extension to an IPG 402. [0063] Figs. 14A-14B provide a more detailed view of the device 400 of Fig. 13. As shown, the structure 200 includes at least one lumen 233 configured to allow passage of at 25 least one element, such as a lead 232 through an opening, ports or slots 234 toward a nerve tissue on a spinal level. Fig. 14A illustrates individual leads 232 advanced through lumens 233 in the slotted structure 200 and exiting through slots 234 disposed near its distal end 236. In this embodiment, the leads 232 each have an electrode tip 238 for stimulating the anatomy, particularly the DRG. The electrode tips 238 of the lead may have a variety of designs, such 30 as a pointed tip which is used to contact or pierce a tissue. Alternatively or in addition, the leads may include electrodes mounted thereon, such as in an array. Or, the tip 238 may be shaped so as to increase contact area or wrap around the DRG (such as illustrated in Fig. 10). 13 WO 2008/070807 PCT/US2007/086696 Or, the tip may have other shapes, such as a coil (Fig. 11). It may also be appreciated that the structure 200 may be disposed in an antegrade position or retrograde position. [0064] In this embodiment, the slotted structure 200 has a flat cross-section (Fig. 14B) wherein the lumens 233 extend in parallel within the structure 200 and the slots 234 are 5 arranged in a staggered fashion across the face of the slotted structure 200 corresponding to the position of the lumens 233. Axial distances between the slots 234are designed to generally direct the leads toward the target DRGs on each spinal level. Adjustment of the actual distance between the leads (X &Y) can be made by movement of the leads 232 within the lumens 233 (advancement, retraction, torquing, etc.), such as illustrated in Figs. 9A-9C. 10 [0065] Once the lead 232 positions have been desirably adjusted, the leads 232 may be fixed in place with the use of a fixing mechanism 240. In this embodiment, the mechanism 240 clamps the slotted structure 200, as illustrated in Fig. 14A, so as to hold the leads 232 in place by frictional forces. Other fixation mechanisms may alternatively be used. [0066] Typically, the slotted structure or shaft 200 is anchored to tissue near the IPG or 15 along the shaft 200 outside of the spinal column. This assists in reducing any possible migration or movement. Thus, in some embodiments, the shaft 200 includes a tissue anchor 445 which may be used to anchor the shaft 200 to the surrounding tissue. In this example, the tissue anchor 445 includes at least one suture hole 447 through which suture may be passed to suture the anchor 445 to the tissue. Optionally, the structure 200 may be fixed to one or more 20 vertebrae. [0067] Figs. 15-17 illustrate another embodiment of a grouped lead system 200 which allows individual placement of leads 232 at various levels while grouping the leads near the proximal end so as to extend out in a bundle to an IPG. Fig. 15 illustrates the placement of a rail, rod, guidewire or other elongate member or structure 250 in an epidural space, 25 particularly longitudinally through the foramens of each vertebrae V. It may be appreciated that the elongate member or structure 250 may be positioned at a variety of locations adjacent or near the DRG while maintaining the longitudinal orientation. [0068] The structure 250 is used to advance individual leads 232 into desired positions near the DRGs or target anatomy. The structure 250 is typically anchored to a vertebrae V as 30 shown, such as with an anchoring device 245, such as a bone tack or bone screw. Referring to Fig. 16, each individual lead 232 includes a lumen 252 extending through at least a portion of the lead 232 that is used for tracking over the structure 250. Each lead also includes at 14 WO 2008/070807 PCT/US2007/086696 least one electrode 210 which is electrically connected to a conductive wire 211 which extends to a power source or IPG. Fig. 17 illustrates a plurality of leads 232 tracked over the structure 250, each lead 232 positioned in a target location near a DRG. It may be appreciated that any number of leads 232 may be advanced over the same structure 250. 5 Further, it may be appreciated that any number of structures 250 may be anchored in various locations for tracking leads to any desired location along the spinal column. The one or more structures 250 may then be left in place to support the leads 232. [0069] The above embodiments describe devices, systems and methods that utilize that directly stimulates the dorsal root, particularly the dorsal root ganglion (DRG), while 10 minimizing or excluding undesired stimulation of other anatomies. In some embodiments, this allows access to multiple levels of the spinal column with the use of a single device. This reduces procedure complexity, time and recovery since a single access path is created rather than individual access paths to each level of the spinal column. These embodiments also have a reduced number of paths to an IPG. It may be appreciated that the devices, 15 systems and methods of the present invention may also be used to stimulate other portions of the spinal anatomy or other anatomies. [0070] Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that various alternatives, modifications and equivalents may be used and the above description 20 should not be taken as limiting in scope of the invention. 15

Claims (22)

1. A delivery device for delivering elements to nerve tissue on different spinal levels, the device comprising: an elongate structure shaped for positioning within an epidural space, wherein the elongate structure has a first opening alignable with a first spinal level and a second opening concurrently alignable with a second spinal level, and wherein the elongate structure includes at least one lumen configured to allow passage of at least one element through the first opening toward nerve tissue on the first spinal level and passage of at least one element through the second opening toward nerve tissue on the second spinal level, wherein the elongate structure comprises a first portion having the first opening and a second portion having the second opening, wherein the first and second portions move relative to each other so as to adjust a distance between the openings.
2. A delivery device as in claim 1, wherein the first and second spinal levels are not adjacent to each other.
3. A delivery device as in any one of claims 1 to 2, wherein the openings face lateral to a midline of the epidural space.
4. A delivery device as in any one of the preceding claims, wherein the first opening faces a direction on the first spinal level and another opening faces in a substantially opposite direction on the first spinal level.
5. A delivery device as in any one of the preceding claims, wherein a distance between the openings is fixed.
6. A delivery device as in any one of the preceding claims, wherein the openings face longitudinal to a midline of the epidural space.
7. A delivery device as in any one of the preceding claims, wherein the at least one lumen comprises an individual lumen extending to the first opening and an individual lumen extending to the second opening. 16
8. A delivery device as in any one of the preceding claims, wherein the first opening is shaped to allow longitudinal translation of the at least one element within the first opening.
9. A delivery device as in claim 8, wherein the first opening has an oblong shape.
10. A delivery device as in any one of the preceding claims, further comprising a mechanism to fix the at least one element in relation to the elongate structure.
11. A method for delivering elements to nerve tissue on different spinal levels comprising: advancing an elongate structure into an epidural space, wherein the elongate structure has a first opening and a second opening; and positioning the elongate structure so that the first opening substantially aligns with a first spinal level the second opening substantially aligns with a second spinal level, wherein the elongate structure comprises a first portion having the first opening and a second portion having the second opening, and wherein positioning comprises moving at least one of the portions in relation to the other.
12. The method of claim 11, further comprising extending a first element through the first opening toward a nerve tissue on the first spinal level.
13. The method of claim 11 or claim 12, wherein the first element comprises a lead having at least one electrode, the method further comprising stimulating the nerve tissue on the first spinal level.
14. The method of claim 13, wherein the nerve tissue comprises a dorsal root ganglion.
15. The method of any one of claims 12 to 14, further comprising manipulating the first element to direct the distal end toward the nerve tissue on the first spinal level.
16. The method of claim 15, wherein manipulating comprises advancing, retracting, torqueing, curving or steering the first element. 17
17. The method of any one of claims 12 to 16, wherein the first element comprises an agent delivery device, the method further comprising delivering an agent to the nerve tissue on the first spinal level with the use of the agent delivery device.
18. The method of any one of claims 12 to 17, further comprising extending a second element through the second opening toward a nerve tissue on the second spinal level.
19. The method of any one of claims 11 to 18, wherein the first and second spinal levels are not adjacent to each other.
20. The method of any one of claims 11 to 19, wherein the elongate structure has a third opening, and wherein positioning comprises aligning the third opening with the first spinal level.
21. The method of claim 20, further comprising extending a first element through the first opening toward a nerve tissue on the first spinal level, and extending a third element through the third opening toward a different nerve tissue on the first spinal level.
22. The method of claim 21, wherein the nerve tissue on the first spinal level comprises a dorsal root ganglion and the different nerve tissue on the first spinal level comprises a different dorsal root ganglion. 18
AU2014201494A 2006-12-06 2014-03-13 Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels Active AU2014201494B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US60/873,535 2006-12-06
US60/873,464 2006-12-06
AU2007329253A AU2007329253B2 (en) 2006-12-06 2007-12-06 Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
AU2014201494A AU2014201494B2 (en) 2006-12-06 2014-03-13 Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2014201494A AU2014201494B2 (en) 2006-12-06 2014-03-13 Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2007329253A Division AU2007329253B2 (en) 2006-12-06 2007-12-06 Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels

Publications (2)

Publication Number Publication Date
AU2014201494A1 AU2014201494A1 (en) 2014-04-17
AU2014201494B2 true AU2014201494B2 (en) 2015-12-03

Family

ID=50480268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014201494A Active AU2014201494B2 (en) 2006-12-06 2014-03-13 Delivery Devices, Systems and Methods for Stimulating Nerve Tissue on Multiple Spinal Levels

Country Status (1)

Country Link
AU (1) AU2014201494B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6425887B1 (en) * 1998-12-09 2002-07-30 Cook Incorporated Multi-directional needle medical device
US6745079B2 (en) * 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
US20040236388A1 (en) * 1998-04-30 2004-11-25 Medtronic, Inc. Techniques for positioning therapy delivery elements within a spinal cord or brain
US20060052839A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods for stimulating a dorsal root ganglion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040236388A1 (en) * 1998-04-30 2004-11-25 Medtronic, Inc. Techniques for positioning therapy delivery elements within a spinal cord or brain
US6425887B1 (en) * 1998-12-09 2002-07-30 Cook Incorporated Multi-directional needle medical device
US6745079B2 (en) * 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
US20060052839A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Methods for stimulating a dorsal root ganglion

Also Published As

Publication number Publication date
AU2014201494A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
US8145299B2 (en) Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US6505075B1 (en) Peripheral nerve stimulation method
US6353762B1 (en) Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US8112159B2 (en) Kit for implantation of therapy elements
EP1904173B1 (en) Implantable medical device with electrodes on multiple housing surfaces
EP2386260B1 (en) Combination electrical stimulating and infusion medical device
US7778704B2 (en) Electrical stimulation of the sympathetic nerve chain
US8233993B2 (en) Winged electrode body for spinal cord stimulation
EP2421600B1 (en) Spinal cord modulation systems for inducing paresthetic and anesthetic effects
US6971393B1 (en) Minimally invasive method for implanting a sacral stimulation lead
US5713922A (en) Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US8323277B2 (en) Combination electrical stimulating and infusion method
US20060259110A1 (en) Collapsible/Expandable Tubular Electrode Leads
ES2587594T3 (en) Multifrequency neuronal treatments and associated systems
EP2373378B1 (en) Selective stimulation systems and signal parameters for medical conditions
JP2007528776A (en) Modular stimulation lead network
US8452417B2 (en) System and method for treating pain with peripheral and spinal neuromodulation
US8027718B2 (en) Regional anesthetic
US20030078633A1 (en) Methods and implantable apparatus for electrical therapy
EP2089095B1 (en) Implantable medical lead with threaded fixation
US8626302B2 (en) Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
US8082039B2 (en) Stimulation systems
EP1341579B1 (en) Directional brain stimulation and recording leads
US5423877A (en) Method and device for acute pain management by simultaneous spinal cord electrical stimulation and drug infusion
Slavin Peripheral nerve stimulation for neuropathic pain

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)